Re:Trump Sends Pharma Stocks Down with New Tweet on Drug Prices
by maxerickson on Tuesday March 07, 2017 @12:53PM
(#13812761)
By "market", I meant selling them, not just advertising.
A Swiss company can get revenue from the US just as well as a US company. The location of their research lab won't reveal where they make their profits.
Even with marketing spends of 20-25% of revenue, and R&D spends of 10% (and profit margins of typically 20%+), pharma has still managed to convince many Americans that they are struggling, and Americans are feeling the burden, of the US subsidizing the world's drug research (even though the two largest researching firms in the world aren't the US).